<a href="https://laohu8.com/S/AEMD">Aethlon Medical Inc</a>. Announces $4.5 Million Public Offering of Common Stock and Warrants
Aethlon Medical Inc., a company specializing in medical therapeutics aimed at treating cancer and infectious diseases, has announced a public offering valued at $4.5 million. The offering includes 5,000,000 shares of common stock or pre-funded warrants, accompanied by warrants to purchase an equal number of shares. Each share or pre-funded warrant, along with the accompanying warrant, is priced at $0.90. The warrants are immediately exercisable and will expire five years from the date of issuance. Maxim Group LLC is serving as the exclusive placement agent for this offering. The proceeds are intended for general corporate purposes, including clinical trials, research and development, capital expenditures, and working capital.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA65685) on September 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.